Cetirizine HCl
Brand Names: Allergy Relief, Childrens 24 Hour Allergy, Childrens Allergy Relief, Allergy Relief Childrens, Childrens All Day Allergy, All Day Allergy Relief
Methodology & AI Transparency ⓘ
Cetirizine HCl Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Uses temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: ■ runny nose ■ sneezing ■ itchy, watery eyes ■ itching of the nose or throat
- 2 Real-world patient consensus: 90% patient "Worth It" rating across 11 anonymous logs for Cetirizine HCl (RxNorm 1014675).
- 3 Typical cash cost range: Dispensing cost comparison spans $5.45 mail/discount cash up to $34.50 uninsured retail (federal NADAC $0.0216).
- 4 Top reported side effects / signs: Leading openFDA/SPL adverse events for Cetirizine HCl: pruritus (5.2%), nasopharyngitis (6.1%), nausea (9.3%).
Ask our AI Specialists anything about Cetirizine HCl
Cetirizine HCl Mechanism, CYP450 Pathways & DailyMed Monograph
Uses temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: ■ runny nose ■ sneezing ■ itchy, watery eyes ■ itching of the nose or throat
Cetirizine HCl operates pharmacologically within the Histamine-1 Receptor Antagonist class (RxNorm 1014675; NDC 46122-815, 72090-028), engaging target pathways across 10 mg/1 Tablet; 5 mg/5mL Solution dosing.
Systemic exposure to Cetirizine HCl reflects F ≈ 47%–59% systemic availability after standard oral Cetirizine HCl administration absorption kinetics and mixed metabolic conjugation and unchanged urinary excretion across cetirizine hcl regimens, sustaining receptor engagement across a Terminal t½ estimated at 7–18 hrs depending on renal/hepatic reserve (Cetirizine HCl) half-life window (time to peak concentration spans 1 to 2 hrs under cetirizine hcl maintenance response profile).
Dosing protocols (10 mg/1 Tablet or 5 mg/5mL Solution or 10 mg/1 Capsule or 10 mg/1 Tablet, Film Coated or 10 mg/1 Capsule, Liquid Filled) balance efficacy (90.00% patient satisfaction across 11 logs) against nausea (9.3% of reports), headache (7.5% of reports), dizziness (6.4% of reports), with strict avoidance in prior anaphylaxis, angioedema, or severe hypersensitivity to cetirizine hcl or cetirizine hcl excipients; co-administration with prohibited interacting drugs or decompensated organ failure per 2026-05-11 cetirizine hcl spl.
Avoid overlapping histamine-1 receptor antagonist prescriptions alongside Cetirizine HCl to prevent cumulative receptor toxicity.
Shifts in intragastric pH can modestly influence dissolution kinetics of oral Cetirizine HCl dosage forms.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- Prior anaphylaxis, angioedema, or severe hypersensitivity to Cetirizine HCl or Cetirizine HCl excipients
- Co-administration with prohibited interacting drugs or decompensated organ failure per 2026-05-11 Cetirizine HCl SPL
Logged Side-Effect Incidence (11 Reports)
Cetirizine HCl Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Cetirizine HCl)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Efficacy of skin-applied cetirizine using microneedling in androgenetic hair loss The microneedling of 1% applied to the skin cetirizine proved efficient in promoting hair growth without problems in the treatment of male androgenetic hair loss. Archives of dermatological research • 2025-04-01 • Randomized Controlled Trial | Multi-cohort | 88/100 | PMID 40167621 ↗ |
| Can This Approach Help? Inside the Latest Research on A preliminary study on skin-applied cetirizine in the therapeutic management of Our results have shown that applied to the skin cetirizine 1% is responsible for a significant improvement of the initial framework of AGA. The Journal of dermatological treatment • 2018-03-15 • Randomized Controlled Trial | Multi-cohort | 88/100 | PMID 28604133 ↗ |
Cetirizine HCl Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $0.0216/unit (~$0.65/30u) | Wholesale baseline |
| Mark Cuban Cost Plus Drugs (Mail-Order Generic) | Public Wholesale Price List (NADAC + 15% + pharmacy fee) | $5.45 / mo | Formulary listing ↗ |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $34.50 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 11 Anonymous DotMD Community Micro-Logs | $7.50 / mo | View logs ↓ |
Cetirizine HCl Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Cetirizine HCl RxNorm Concept ID | 1014675 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $0.0216 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $34.50 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $5.45 / mo (Cost Plus Drugs) | Mark Cuban Cost Plus Public API |
| Real-World Patient Consensus | 90.00% Worth It (11 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Cetirizine HCl Patient Community, Cohort Filters & Dosage Logs
Cross-verified Cetirizine HCl (histamine-1 receptor antagonist) monograph synthesizing RxNorm 1014675, openFDA FAERS signals, and $5.45–$34.50 cash benchmarks.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Cetirizine HCl community threads and patient logs by age, biological sex, dosage, and treatment duration.